Get 20% Free Customization In This Report

Buy this report from - $3456

Medical Marijuana Market by Medical Application (Chronic Pain, Migraine, Cancer, Arthritis, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_182957	Pages: NA	Jun 2018 \| 763 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Marijuana refers to the dried leaves, flowers, stems, and seeds from the hemp plantCannabis sativa. There are 2 main active chemicals in Marijuanacannabidiol (CBD) and tetrahydocannabinol (THC), which impact the brain and relieve the pain, respectively. Marijuana provides pain relief in conditions such as fibromyalgia, grand mal seizures, and other medical conditions. Similarly, it reduces symptoms of many serious medical conditions such as AIDS, cancer, and glaucoma.

The increase in prevalence of diseases and growth in demand for relieving pain in conditions such as cancer, AIDS, seizures, and other diseases majorly drive the medical marijuana market. In 2016, countries such as Colombia, Macedonia, Israel, Germany, Australia, and others allowed the medical use of marijuana.

Thus, rise in number of countries legalizing the use of medical marijuana is anticipated to fuel the growth of the market during the forecast period. Furthermore, the stringent rules and regulations associated with the medical marijuana such as Medical Marijuana Regulation and Safety Act and increase in number of license issued every year stipulates demand of Marijuana in market.

Moreover, growth in investment in R&D and increase in business strategies by companies of marijuana is expected to impel the market growth. For instance, in 2016, Gibraltar Industries acquired Nexus Corporation strengthening its position as greenhouse manufacturer and distributor. However, complex regulatory framework to obtain license majorly hinders the medical marijuana market.

The market is segmented on the basis of medical application and geography. By medical applications, the market is categorized into chronic pain, migraine, cancer, arthritis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the global medical marijuana market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Medical Marijuana Market Key Segments:

By Medical Application

Chronic Pain
Migraine
Cancer
Arthritis
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- Spain
- Italy
- Netherlands
- Russia
- Switzerland
- Rest of Europe
Asia Pacific
- India
- Australia
- Rest of Asia Pacific
LAMEA
- South Africa
- Chile
- Columbia
- Israel
- Turkey
- Rest of LAMEA

List of players profiled in the report

Cara Therapeutics Inc.
Canopy Growth
Insys Therapeutics
CannaGrow Holdings, Inc.
Cannabis Sativa, Inc.
Arena Pharmaceuticals
Aphria
GW Pharmaceuticals, plc
Lexaria Corp
International Consolidated Companies, Inc.

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 MEDICAL MARIJUANA MARKET, BY MEDICAL APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CHRONIC PAIN

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. MIGRAINE

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CANCER

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. ARTHRITIS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. OTHERS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

Chapter: 5 MEDICAL MARIJUANA MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America Medical Marijuana Market by Medical Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. Spain market size and forecast
5.3.3.3. Italy market size and forecast
5.3.3.4. Netherlands market size and forecast
5.3.3.5. Russia market size and forecast
5.3.3.6. Switzerland market size and forecast
5.3.3.7. Rest of Europe market size and forecast

5.3.4. Europe Medical Marijuana Market by Medical Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. India market size and forecast
5.4.3.2. Australia market size and forecast
5.4.3.3. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific Medical Marijuana Market by Medical Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. South Africa market size and forecast
5.5.3.2. Chile market size and forecast
5.5.3.3. Columbia market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. Turkey market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast

5.5.4. LAMEA Medical Marijuana Market by Medical Application

Chapter: 6 COMPANY PROFILES

6.1. CARA THERAPEUTICS INC.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. CANOPY GROWTH

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. INSYS THERAPEUTICS

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. CANNAGROW HOLDINGS, INC.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. CANNABIS SATIVA, INC.

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. ARENA PHARMACEUTICALS

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. APHRIA

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. GW PHARMACEUTICALS, PLC

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. LEXARIA CORP

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. INTERNATIONAL CONSOLIDATED COMPANIES, INC.

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.